Resistance to Insulin-Like Growth Factor I
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
55
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Urothelial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
449
|
10
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Adult Erythroleukemia
|
disease |
|
Neoplastic Process
|
236
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute Myeloid Leukemia with Gene Mutations
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Myeloid neoplasm
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
62
|
5
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
MYOTONIC DYSTROPHY 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
179
|
14
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
High Grade Liver Dysplastic Nodule
|
disease |
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Apparent mineralocorticoid excess
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
23
|
15
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
MIXED LINEAGE LEUKEMIA
|
disease |
|
Neoplastic Process
|
240
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Peripheral arterial stenosis
|
disease |
|
Disease or Syndrome
|
124
|
5
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
cervical cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1817
|
268
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Erythroleukemia (Erythroid/Myeloid)
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
237
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Myelodysplastic Syndrome Acute Myeloid Leukemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Lymphoma, Non-Hodgkin, Familial
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
462
|
79
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Peripheral Arterial Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
319
|
128
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
919
|
110
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Leukaemia recurrent
|
disease |
Neoplasms
|
Neoplastic Process
|
50
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Atypical Lipoma
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
2
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Acute myeloid leukemia with recurrent genetic abnormality
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Precursor B-cell lymphoblastic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
478
|
23
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |